SCHEMBL22433298

SCHEMBL22433298

CC(C)c1cccc(C(C)C)c1NC(=O)NS(=O)(=O)C1CN(CC(F)(F)F)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20635801 0.93 MEN1 (0.46) —
SCHEMBL22433562 0.91 MEN1 (0.49) —
SCHEMBL20636166 0.89 MEN1 (0.46) —
SCHEMBL22433299 0.88 GSTO1 (0.37) —
SCHEMBL20636110 0.87 NLRP3 (0.45) —
SCHEMBL22433294 0.86 — —
SCHEMBL20636116 0.86 GSTO1 (0.41) —
SCHEMBL20635141 0.85 — —
SCHEMBL22433553 0.84 NLRP3 (0.54) —
SCHEMBL22433379 0.82 NLRP3 (0.52) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230037255-A1 NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS INFLAZOME LTD (IE) 2023-02-02 — — US disclosed
US-20200291003-A1 NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS SYGNATURE DISCOVERY LIMITED (GB) 2020-09-17 — — US disclosed
Send feedback